News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Florian Lordick: Honoured having received the FESMO award from ESMO President Andres Cervantes
Photo from Florian Lordick/Twitter
Oct 23, 2023, 13:21

Florian Lordick: Honoured having received the FESMO award from ESMO President Andres Cervantes

Florian Lordick, Professor of Medicine and Director of the University Cancer Center Leipzig, shared on X/Twitter:

”Honoured having received the FESMO award from ESMO President Andres Cervantes yesterday night.”

Source: Florian Lordick/Twitter

Andres Cervantes cancer ESMO FESMO Florian Lordick OncoDaily Oncology
Special Coverage
Blog
Mar 31, 2025, 18:15
Beau Bosko Toskich: Clinical and Dosimetric Guidelines for Y-90 Glass Microsphere Radioembolization
Blog
Mar 31, 2025, 18:09
Ray Chan: Can’t wait for William Dale’s lecture this Thursday at Flinders University
Science
Mar 31, 2025, 18:00
Partha Basu: Guidance from IARC/WHO on validating HPV detection tests with lower valency
Blog
Mar 31, 2025, 17:58
Trends in Outpatient Opioid Prescriptions for Cancer Pain Between 2016 and 2021
Blog
Mar 31, 2025, 17:50
Lauren Averett Byers: Awesome clinic with Dr. Elyse Rose Lopez
Blog
Mar 31, 2025, 17:45
Lianne Mandelbaum: Flying with food allergies - Combating misconceptions and advocating for safety
Blog
Mar 31, 2025, 17:01
Navigating care: understanding cancer patients’ experiences with systemic radionuclide therapy - MASCC
Blog
Mar 31, 2025, 16:46
Join Dr. Nicola Normanno at ISMRC 2025 for insights on biomarker discovery and ctDNA testing
Career
Mar 31, 2025, 16:23
Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy
Blog
Mar 31, 2025, 15:57
Register Today for the 2025 Breast Cancer Symposium
Blog
Mar 31, 2025, 15:45
Allison Betof Warner: Last Call for Abstracts to the 2025 SNO/ASCO CNS Metastasis Conference
Blog
Mar 31, 2025, 15:33
Luis Moreno Sánchez: Reirradiation in the Management of Locally Recurrent Rectal Adenocarcinoma